CA: A Cancer Journal for Clinicians

Publisher information for authors

Author requirements

Send a proposed outline and abstract, author information and manuscript length for approval before submitting an unsolicited paper. Approved manuscripts use ScholarOne. Unsolicited case reports and letters are not considered.

Peer review

Editors select external reviewers and decide whether to accept a manuscript.

Fees and licence

The author guidelines state that CC BY-NC-ND publication is free; other required licences can incur an APC. There are no submission, page or colour charges.

2025 publisher-reported metrics

Journal Impact Factor 685.2; CiteScore 649.8; acceptance rate 31%. Median submission-to-first-decision: 2 days; submission-to-acceptance: 28 days; acceptance-to-publication: 39 days. These statistics do not predict an individual manuscript’s outcome.

Publisher sources checked 2026-10-03. Policies can change; follow the linked instructions when preparing a submission.

• Journal overview and editor
• Author guidelines, fees and licensing
• 2025 journal metrics
• Phase III trial proposal requirements

Source-backed journal facts

Topics in published research

Advances in Oncology and Radiotherapy; Global Cancer Incidence and Screening; Cancer Treatment and Pharmacology; BRCA gene mutations in cancer; Economic and Financial Impacts of Cancer; Cancer survivorship and care.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.